- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04166994
Pilot of IMPACT Intervention at the University of New Mexico (IMPACT)
May 8, 2023 updated by: Larissa Myaskovsky, PhD, University of New Mexico
Improving Healthcare Outcomes in American Indian and Hispanic Transplant Recipients Using Culturally-Tailored Novel Technology (IMPACT)
Kidney transplant recipients (KTR) are at greater risk of weight gain, diabetes and cardiovascular events post-transplant; but medications are limited in their effectiveness, and patients may face contraindications and unwanted side effects, given their complex post-transplant immunosuppression regimen.
The investigators will pilot a randomized-controlled trial to test the feasibility and acceptability of a culturally-appropriate, multi-behavior (diet and exercise) lifestyle intervention for 20 American Indian, Hispanic/Latino(a), and White KTRs.
Critical components of the pilot trial include: (a) an individually tailored exercise and diet plan with a physical therapist/exercise physiologist and a registered dietitian nutritionist, who will work closely with the post-transplant team to carefully monitor patient stability; and, (b) the use of the Twistle Patient Engagement Platform to follow-up with participants between their scheduled appointments and to collect all questionnaire data.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
In Improving Healthcare Outcomes in American Indian and Hispanic Transplant Recipients Using Culturally-Tailored Novel Technology (IMPACT), the investigators will pilot the feasibility and acceptability of a culturally-tailored, multi-behavior lifestyle intervention using a novel technology for 14-20 AI, HL, and White KT recipients.
Because of KT recipients' varied stability immediately post-transplant, and the need to individually monitor their post-transplant immunosuppression regimen, a critical component of IMPACT will be an individually-tailored exercise and diet plan with a physical therapist/exercise physiologist and a registered dietitian nutritionist, who will work closely with the post-transplant team to carefully monitor patient stability.
IMPACT will combine a personalized assessment of the patient's food preferences and access to exercise resources within their environment (based on a standard list of factors developed by the nutrition and rehabilitation experts) along with clinical specifications from the transplant team.
The study is innovative because it addresses previous limitations, while adapting the intervention to meet the needs of the culturally-diverse ESKD population.
The final innovation of the IMPACT Pilot is the use of the Twistle Patient Engagement Platform to follow-up with participants between their scheduled appointments, ensure adherence to the intervention, collect all questionnaire data, and enhance participant retention.
Study Type
Interventional
Enrollment (Actual)
23
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New Mexico
-
Albuquerque, New Mexico, United States, 87131
- University of New Mexico
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Received kidney transplant at UNMH
- Greater than 18 years of age
- Mentally competent
Exclusion Criteria:
- Children under the age of 18
- Incarcerated patients
- Pregnant women
- Active systemic infection
- Non-skin malignancy or melanoma in the past 2 years
- Known cognitive impairment
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: IMPACT Intervention
Incorporate a rehabilitation approach to slowly increasing KT recipients' physical activity in addition to individualized dietary intervention at every post-transplant appointment through six months post-transplant, with follow-up at 12 months post-transplant.
|
IMPACT Intervention
|
Other: Usual Care
No exercise or diet specialization.
|
No exercise or diet specialization.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Intervention Acceptability: Satisfaction
Time Frame: 12 months
|
Client Satisfaction Questionnaire, rated 1-4, where higher satisfaction will indicate greater intervention acceptability
|
12 months
|
Intervention Acceptability: Usability
Time Frame: 12 months
|
System Usability Scale, rated 1-5, where higher scores indicate ease of usability
|
12 months
|
Intervention feasibility: Retention
Time Frame: Through study completion, an average of 1 year
|
Retention rates
|
Through study completion, an average of 1 year
|
Intervention feasibility: Missing data
Time Frame: Through study completion, an average of 1 year
|
Estimates of the expected rates of missing data
|
Through study completion, an average of 1 year
|
Intervention feasibility: Attrition
Time Frame: Through study completion, an average of 1 year
|
Participant attrition will be measured by counting participants who do not continue with the study
|
Through study completion, an average of 1 year
|
Intervention feasibility: Participation
Time Frame: Through study completion, an average of 1 year
|
Time required for study participation during every intervention session
|
Through study completion, an average of 1 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Medical records outcomes: Weight
Time Frame: Through study completion, an average of 1 year
|
Percent weight change
|
Through study completion, an average of 1 year
|
Medical records outcomes: Lipids
Time Frame: Through study completion, an average of 1 year
|
Total cholesterol: Less than 200 mg/dL, LDL: Less than 100 mg/dL, HDL: 60 mg/dL or higher, Triglycerides: less than 150 mg/dL
|
Through study completion, an average of 1 year
|
Medical records outcomes: HbA1c
Time Frame: Through study completion, an average of 1 year
|
HbA1c
|
Through study completion, an average of 1 year
|
Patient reported outcomes: Sleep
Time Frame: Baseline, 1 year
|
Pittsburgh Sleep Quality Index will measure different aspects of sleep and becomes one composite score, where lower scores denote a healthier sleep quality
|
Baseline, 1 year
|
Patient reported outcomes: QOL
Time Frame: Baseline, 1 year
|
We will use the PROMIS Scale v1.2 Global Health measure to assess quality of life (QOL), which includes items relevant to patients with kidney disease, including overall health, physical limitations, work, pain, energy, and emotional problems.
|
Baseline, 1 year
|
Patient reported outcomes: Occupational
Time Frame: Baseline, 1 year
|
Occupational Functioning Subscale: CHART-SF rated 0-100, where higher scores indicate greater levels of participation
|
Baseline, 1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Larissa Myaskovsky, PhD, University of New Mexico
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 1, 2020
Primary Completion (Actual)
January 13, 2023
Study Completion (Actual)
January 13, 2023
Study Registration Dates
First Submitted
October 30, 2019
First Submitted That Met QC Criteria
November 15, 2019
First Posted (Actual)
November 18, 2019
Study Record Updates
Last Update Posted (Actual)
May 9, 2023
Last Update Submitted That Met QC Criteria
May 8, 2023
Last Verified
May 1, 2023
More Information
Terms related to this study
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Kidney Replacement
-
Lancashire Teaching Hospitals NHS Foundation TrustRecruitingUtilising Volumetric Absorptive Microsampling (VAMS) Technology to Monitor Tacrolimus and CreatinineKidney Transplant Rejection | Kidney ReplacementUnited Kingdom
-
Mario Negri Institute for Pharmacological ResearchNot yet recruiting
-
Chiang Mai UniversityCompletedKidney Transplant Rejection | Kidney Replacement | Plasmapheresis
-
Klinik für AnästhesiologieWithdrawnKidney Replacement DisorderGermany
-
Mario Negri Institute for Pharmacological ResearchNot yet recruiting
-
Medical University of GdanskCompletedAcute Kidney Injury | Renal Replacement Therapy | Acute Kidney Failure | HemofiltrationPoland
-
Adhera Health, Inc.Maastricht University Medical Center; Hospital Universitario Reina Sofia de... and other collaboratorsCompletedKidney Cancer | Scoliosis | Prostate Cancer | Bladder Cancer | Knee Replacement | Orthognathic Surgery | Coronary Artery Bypass Surgery | Hip Replacement | Psychological Stress | Cardiopulmonary Bypass Surgery | Cardiac Valve ReplacementNetherlands, Spain, Italy
-
University of RostockUnknownAcute Kidney Injury | Renal Replacement TherapyGermany
-
Peking Union Medical College HospitalCompletedCritical Illness | Coagulation; Intravascular | Kidney Replacement DisorderChina
-
Centre Hospitalier Universitaire VaudoisCompletedReferral Patterns for Hospital Acquired Acute Kidney Injury and Relevance to Renal Outcomes (HA-AKI)Mortality | Renal Replacement TherapySwitzerland
Clinical Trials on Exercise and diet
-
Göteborg UniversityThe Swedish Research Council; Swedish Council for Working Life and Social ResearchCompleted
-
Florida International UniversityTerminatedDiabetes | Frailty | Senior SyndromeUnited States
-
Rabin Medical CenterSoroka University Medical Center; D-Cure, IsraelCompleted
-
University of PittsburghUniversity of PennsylvaniaCompleted
-
USDA Grand Forks Human Nutrition Research CenterWithdrawn
-
Changi General HospitalCompletedQuality of Life | Inflammation | Sexual Dysfunction | Endothelial DysfunctionSingapore
-
Universidade Católica PortuguesaAssociação para o Desenvolvimento do Centro Académico de Investigação e Formação...Active, not recruitingCardiovascular Disease RiskPortugal
-
American Scitech InternationalProactive Clinical ResearchUnknownType II Diabetes MellitusUnited States, India
-
University of AlexandriaCompleted
-
Texas Tech University Health Sciences CenterCompleted